Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population (Tele-PD)

This study has been completed.
Sponsor:
Collaborator:
Presbyterian Home for Central New York, Inc.
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT00668551
First received: April 25, 2008
Last updated: April 10, 2009
Last verified: April 2009

April 25, 2008
April 10, 2009
April 2008
November 2008   (final data collection date for primary outcome measure)
The feasibility of telemedicine, based on participant ability to complete 75% or more of the trial visits. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00668551 on ClinicalTrials.gov Archive Site
  • Parkinson's Disease Questionnaire-39 (PDQ-39) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • EuroQol (EQ-5D) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Geriatric Depression Scale Short Form (GDS-15) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Modified Group Health Association of America's Consumer Satisfaction Survey (GHAA) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Qualitative assessment, including a telemedicine focus group and 1:1 interviews with study participants [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Same as current
 
 
 
Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population
Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population

To eliminate barriers (such as travel and cost) to specialized Parkinson disease (PD) care, two movement disorder specialists at the University of Rochester will be providing telemedicine visits for patients with PD who reside in the Presbyterian Home for Central New York in New Hartford, NY, or for individuals who participate in the local support group that meets at the nursing home. Participants will attend 3 telemedicine visits at the Presbyterian Home over the course of 6 months.

We hypothesize that this telemedicine model will in time improve access to care and hence the quality of life and quality of care of individuals with PD.

Study participants are recruited from the Presbyterian Home and from the Central New York Parkinson Support Group. Anyone interested will attend a screening and baseline visit at the Presbyterian Home, where they will receive baseline surveys and a motor assessment. Eligible participants will be randomized to receive either telemedicine or standard of care.

Each telemedicine visit (Month 1, Month 3, Month 6) will take place in a 1:1 fashion between the study participant and the physician investigator - one of two movement disorder specialists from the University of Rochester - via televideo linkage, and will last approximately 30-60 minutes. The study participant will be observed by the physician investigator and she/he will be accompanied by a Presbyterian Home staff member to ensure safety throughout the telemedicine visit. The visit will be structured much the same as a standard clinical visit and will include:

  • Study participant's update on his or her clinical condition
  • Review of current medications, which will be provided in advance of the visit
  • Review and update of medical and social histories
  • Vital signs, including weight (provided by the Presbyterian Home staff)
  • Pertinent neurological exam, including a modified motor examination led by physician investigator
  • Assessment of current clinical state
  • Dictated recommendations including a letter to the attending physician for ongoing clinical care, including changes to the PD medications

Participants assigned to the control group will receive their care as routinely scheduled with their own primary care physician and/or neurologist.

Staff members from the University of Rochester will return to the Presbyterian Home within one month of the six month study to complete final assessments with all study participants. These will include:

  • Reportable events form
  • Health care events form
  • Quality of life and healthcare evaluation surveys
  • Continuation of care survey
  • 1:1 interviews
  • Telemedicine focus groups
Observational
Observational Model: Cohort
Time Perspective: Prospective
 
Non-Probability Sample

Study participants will be recruited from the Presbyterian Home Parkinson disease nursing home, assisted living, independent living, and adult day care populations, as well as the local PD support group that meets monthly at the Presbyterian Home.

Parkinson Disease
 
  • 1
    Telemedicine care
  • 2
    Standard of care

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
14
November 2008
November 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Willing and able to provide informed consent
  • Age 30 years old or older
  • Clinical diagnosis of idiopathic Parkinson's disease as determined by having two of the four cardinal features of PD (rest tremor, bradykinesia, cogwheel rigidity, and gait instability) and no better alternative explanation for the etiology of the symptoms
  • Able to converse in English
  • Willing and able to complete study requirements

Exclusion Criteria:

  • Any neurological, medical, or psychiatric condition that would preclude the patient having the ability to provide informed consent or to participate in the telemedicine visit.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00668551
RSRB00022923
No
E. Ray Dorsey, MD, MBA, University of Rochester
University of Rochester
Presbyterian Home for Central New York, Inc.
Principal Investigator: E. Ray Dorsey, MD, MBA University of Rochester
Principal Investigator: Kevin Biglan, MD, MPH University of Rochester
University of Rochester
April 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP